Aimmune Therapeutics Inc.’s treatment for peanut allergy successfully desensitized patients in a midstage trial. If eventually approved, it would be the first oral drug for the condition. Click here for more details.
Aimmune Therapeutics Inc.’s treatment for peanut allergy successfully desensitized patients in a midstage trial. If eventually approved, it would be the first oral drug for the condition. Click here for more details.